Castration-Resistant Prostatic Neoplasms
Showing 1 - 25 of 7,136
Castration-Resistant Prostatic Cancer Trial ([Lu-177]-PNT2002)
Available
- Castration-Resistant Prostatic Cancer
- (no location specified)
Sep 11, 2023
Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone acetate)
Not yet recruiting
- Prostatic Neoplasms
- Metastatic Castration-Resistant Prostate Cancer
- MK-5684
- +3 more
- (no location specified)
Oct 23, 2023
Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone)
Not yet recruiting
- Prostatic Neoplasms
- Metastatic Castration-Resistant Prostate Cancer
- MK-5684
- +3 more
- (no location specified)
Nov 13, 2023
Prostatic Tumors, Castration-Resistant Trial in Multiple Locations (Radium-223 dichloride (Xofigo, BAY 88-8223))
Active, not recruiting
- Prostatic Neoplasms, Castration-Resistant
- Radium-223 dichloride (Xofigo, BAY 88-8223)
-
Multiple Locations, Japan(unnamed)
Feb 2, 2023
Medicines Called Enzalutamide and Abiraterone in People With
Not yet recruiting
- Prostatic Neoplasms, Castration-Resistant
- Enzalutamide
- Abiraterone acetate
-
New York, New YorkPfizer Inc
Jul 21, 2023
Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Tumors, Prostate Cancer Recurrent Trial (lorigerlimab,
Not yet recruiting
- Androgen-Independent Prostatic Cancer
- +8 more
- lorigerlimab
- +2 more
- (no location specified)
May 4, 2023
Prostatic Tumors, Castration-Resistant Trial in New York (TVB-2640, Enzalutamide)
Not yet recruiting
- Prostatic Neoplasms, Castration-Resistant
-
New York, New YorkWeill Cornell Medicine/NewYork-Presbyterian Hospital
Feb 23, 2023
Metastatic Castration-resistant Prostate Cancer Trial (ONCT-534)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- (no location specified)
Jun 15, 2023
Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Bortezomib)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Sep 7, 2023
Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Prostatic Neoplasms
- MK-5684
- +6 more
- (no location specified)
Nov 21, 2023
Prostate Cancer, Prostatic Cancer, Cancer of Prostate Trial (NUV-422, Enzalutamide)
Not yet recruiting
- Prostate Cancer
- +7 more
- (no location specified)
Jan 12, 2022
Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- Testosterone Cypionate
- Sipuleucel-T
-
New Haven, ConnecticutYale Cancer Center
Oct 20, 2023
Metastasis Castration Resistant Prostate Cancer(mCRPC) Trial (HS-20093)
Not yet recruiting
- Metastasis Castration Resistant Prostate Cancer(mCRPC)
- (no location specified)
Aug 14, 2023
Prostate Cancer, Refractory Cancer, Castration Resistant Prostatic Cancer Trial in Winston-Salem (Omeprazole 80 mg twice daily)
Recruiting
- Prostate Cancer
- +2 more
- Omeprazole 80 mg twice daily
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Jan 5, 2023
Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in
Recruiting
- Castration-Resistant Prostatic Cancer
- +4 more
- ARAT
- +2 more
-
Orange City, Florida
- +1 more
Nov 23, 2022
Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy
Recruiting
- PSMA-positive Metastatic Castration-resistant Prostate Cancer Treated With PSMA Radionuclide Therapy
- PSMA radionuclide therapy
-
Dallas, TexasMethodist Dallas Medical Center
Aug 9, 2023
Prostatic Tumors, Castration-Resistant Trial in Brisbane ([212Pb]Pb-ADVC001)
Not yet recruiting
- Prostatic Neoplasms
- Castration-Resistant
-
Brisbane, Queensland, AustraliaRoyal Brisbane & Women's Hospital
Feb 9, 2023
Metastatic Castration Resistant Prostate Cancer Trial in London (IMU-935)
Recruiting
- Metastatic Castration Resistant Prostate Cancer
-
London, United KingdomInstitute of Cancer Research
Jan 31, 2023
Castration-Resistant Prostate Cancer Trial (SHR3680 tablets)
Not yet recruiting
- Castration-Resistant Prostate Cancer
- SHR3680 tablets
- (no location specified)
Nov 1, 2022
Prostatic Tumors, Castration-Resistant Trial in Rotterdam (Radionuclide Therapy)
Recruiting
- Prostatic Neoplasms, Castration-Resistant
- Radionuclide Therapy
-
Rotterdam, Zuid-Holland, NetherlandsErasmus Medical Center
Jun 5, 2023
Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Enfortumab vedotin)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- Enfortumab vedotin
-
Salt Lake City, UtahHuntsman Cancer Institute
Jan 24, 2023
Metastatic Castration-resistant Prostate Cancer Trial (Disitamab Vedotin(RC48-ADC))
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- Disitamab Vedotin(RC48-ADC)
- (no location specified)
Jul 13, 2023